235MO Efficacy and Safety of Ribociclib (RIB) + Nonsteroidal Aromatase Inhibitor (NSAI) in Younger Patients (pts) with HR+/HER2− Early Breast Cancer (EBC) in NATALEE

S. Loi,E. Stringer-reasor, J-S. Frenel,M. Reinisch,R. ORegan,M. De Laurentiis, Y.H. Park, A. O'Dea,Y-S. Lu, V. Gonzalez, M. Gao, S. Waters, H. Hu, B. Xu

Annals of Oncology（2024）

Cited 0|Views1

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined